rec. | Subject | Hit Length | Description | Align.Len | E value | Bit score | % ident. | % pos. | GO associations |
181 | P33368 | 253 | YOHF_ECOLI Uncharacterized oxidoreductase yoh... | 253 | 0.000000005 | 59.3 | 22 | 42 | | | | | | | | | | | GO:0000166; F:nucleotide binding; IEA:InterPro.::GO:0016491; F:oxidoreductase activity; IEA:UniProtKB-KW. | | | | | | | | | | | 182 | D4A1J4 | 245 | BDH2_RAT 3-hydroxybutyrate dehydrogenase type... | 265 | 0.000000006 | 58.9 | 24 | 39 | GO:0005737; C:cytoplasm; IEA:UniProtKB-SubCell. | | | | | | | | | | GO:0003858; F:3-hydroxybutyrate dehydrogenase activity; IEA:EC.::GO:0016628; F:oxidoreductase activity, acting on the CH-CH group of donors, NAD or NADP as acceptor; ISS:UniProtKB. | | | | | | | | | | GO:0042168; P:heme metabolic process; ISS:UniProtKB.::GO:0055072; P:iron ion homeostasis; ISS:UniProtKB.::GO:0019290; P:siderophore biosynthetic process; ISS:UniProtKB. | 183 | Q3T0C2 | 266 | PGDH_BOVIN 15-hydroxyprostaglandin dehydrogen... | 137 | 0.000000006 | 59.3 | 36 | 47 | GO:0005737; C:cytoplasm; IEA:UniProtKB-SubCell. | | | | | | | | | | GO:0016404; F:15-hydroxyprostaglandin dehydrogenase (NAD+) activity; IDA:UniProtKB.::GO:0070403; F:NAD+ binding; ISS:UniProtKB.::GO:0004957; F:prostaglandin E receptor activity; ISS:UniProtKB. | | | | | | | | | | GO:0097070; P:ductus arteriosus closure; ISS:UniProtKB.::GO:0060206; P:estrous cycle phase; IEP:UniProtKB.::GO:0007565; P:female pregnancy; ISS:UniProtKB.::GO:0045786; P:negative regulation of cell cycle; ISS:UniProtKB.::GO:0030728; P:ovulation; ISS:UniProtKB.::GO:0007567; P:parturition; ISS:UniProtKB.::GO:0006693; P:prostaglandin metabolic process; IDA:UniProtKB.::GO:0070493; P:thrombin receptor signaling pathway; ISS:UniProtKB.::GO:0007179; P:transforming growth factor beta receptor signaling pathway; ISS:UniProtKB. | 184 | O02691 | 261 | HCD2_BOVIN 3-hydroxyacyl-CoA dehydrogenase ty... | 138 | 0.000000007 | 58.9 | 33 | 51 | | | | | | | | | | | GO:0047015; F:3-hydroxy-2-methylbutyryl-CoA dehydrogenase activity; IEA:EC.::GO:0003857; F:3-hydroxyacyl-CoA dehydrogenase activity; IEA:EC.::GO:0000166; F:nucleotide binding; IEA:InterPro. | | | | | | | | | | GO:0008033; P:tRNA processing; IEA:UniProtKB-KW. | 185 | Q9MYP6 | 270 | DHB14_BOVIN 17-beta-hydroxysteroid dehydrogen... | 261 | 0.000000008 | 58.9 | 29 | 39 | | | | | | | | | | | GO:0000166; F:nucleotide binding; IEA:InterPro. | | | | | | | | | | | 186 | Q9X6U2 | 258 | BDHA_CUPNH D-beta-hydroxybutyrate dehydrogena... | 133 | 0.000000009 | 58.5 | 34 | 50 | | | | | | | | | | | GO:0003858; F:3-hydroxybutyrate dehydrogenase activity; IEA:EC.::GO:0000166; F:nucleotide binding; IEA:InterPro. | | | | | | | | | | | 187 | Q8JZV9 | 245 | BDH2_MOUSE 3-hydroxybutyrate dehydrogenase ty... | 264 | 0.00000001 | 58.2 | 24 | 39 | GO:0005737; C:cytoplasm; ISS:HGNC. | | | | | | | | | | GO:0003858; F:3-hydroxybutyrate dehydrogenase activity; ISS:HGNC.::GO:0051287; F:NAD binding; ISS:HGNC.::GO:0016628; F:oxidoreductase activity, acting on the CH-CH group of donors, NAD or NADP as acceptor; IMP:UniProtKB. | | | | | | | | | | GO:0006635; P:fatty acid beta-oxidation; ISS:HGNC.::GO:0042168; P:heme metabolic process; ISS:UniProtKB.::GO:0055072; P:iron ion homeostasis; IMP:UniProtKB.::GO:0019290; P:siderophore biosynthetic process; IMP:UniProtKB. | 188 | P50941 | 241 | FABG_RICPR 3-oxoacyl-[acyl-carrier-protein] r... | 257 | 0.00000001 | 58.2 | 25 | 42 | | | | | | | | | | | GO:0004316; F:3-oxoacyl-[acyl-carrier-protein reductase (NADPH) activity; ISS:UniProtKB.::GO:0051287; F:NAD binding; IEA:InterPro.::GO:0050661; F:NADP binding; ISS:UniProtKB. | | | | | | | | | | GO:0030497; P:fatty acid elongation; ISS:UniProtKB.] | 189 | P06234 | 245 | NODG_RHIME Nodulation protein G OS=meliloti).... | 257 | 0.00000001 | 58.2 | 27 | 40 | | | | | | | | | | | GO:0004316; F:3-oxoacyl-[acyl-carrier-protein reductase (NADPH) activity; IEA:InterPro.::GO:0051287; F:NAD binding; IEA:InterPro. | | | | | | | | | | GO:0006633; P:fatty acid biosynthetic process; IEA:InterPro.::GO:0009877; P:nodulation; IEA:UniProtKB-KW.] | 190 | P50842 | 254 | KDUD_BACSU 2-dehydro-3-deoxy-D-gluconate 5-de... | 266 | 0.00000001 | 58.2 | 24 | 43 | | | | | | | | | | | GO:0047001; F:2-dehydro-3-deoxy-D-gluconate 5-dehydrogenase activity; IEA:EC.::GO:0008678; F:2-deoxy-D-gluconate 3-dehydrogenase activity; IEA:InterPro.::GO:0051287; F:NAD binding; IEA:InterPro. | | | | | | | | | | | 191 | Q4A054 | 234 | Y0419_STAS1 Uncharacterized oxidoreductase SS... | 142 | 0.00000001 | 57.8 | 32 | 50 | | | | | | | | | | | GO:0000166; F:nucleotide binding; IEA:InterPro.::GO:0016491; F:oxidoreductase activity; IEA:UniProtKB-KW. | | | | | | | | | | | 192 | Q8VCC1 | 269 | PGDH_MOUSE 15-hydroxyprostaglandin dehydrogen... | 137 | 0.00000001 | 58.2 | 36 | 47 | GO:0005737; C:cytoplasm; IEA:UniProtKB-SubCell. | | | | | | | | | | GO:0016404; F:15-hydroxyprostaglandin dehydrogenase (NAD+) activity; ISS:UniProtKB.::GO:0070403; F:NAD+ binding; ISS:UniProtKB.::GO:0004957; F:prostaglandin E receptor activity; ISS:UniProtKB. | | | | | | | | | | GO:0097070; P:ductus arteriosus closure; IMP:UniProtKB.::GO:0007565; P:female pregnancy; ISS:UniProtKB.::GO:0045786; P:negative regulation of cell cycle; ISS:UniProtKB.::GO:0030728; P:ovulation; ISS:UniProtKB.::GO:0007567; P:parturition; ISS:UniProtKB.::GO:0006693; P:prostaglandin metabolic process; ISS:UniProtKB.::GO:0070493; P:thrombin receptor signaling pathway; ISS:UniProtKB.::GO:0007179; P:transforming growth factor beta receptor signaling pathway; ISS:UniProtKB. | 193 | P72332 | 245 | NODG_RHIS3 Nodulation protein G OS=Rhizobium ... | 257 | 0.00000001 | 57.8 | 26 | 42 | | | | | | | | | | | GO:0004316; F:3-oxoacyl-[acyl-carrier-protein reductase (NADPH) activity; IEA:InterPro.::GO:0051287; F:NAD binding; IEA:InterPro. | | | | | | | | | | GO:0006633; P:fatty acid biosynthetic process; IEA:InterPro.::GO:0009877; P:nodulation; IEA:UniProtKB-KW.] | 194 | Q8WNV7 | 279 | DHRS4_PIG Dehydrogenase/reductase SDR family ... | 263 | 0.00000001 | 58.2 | 25 | 42 | GO:0005739; C:mitochondrion; ISS:UniProtKB.::GO:0005777; C:peroxisome; IEA:UniProtKB-SubCell. | | | | | | | | | | GO:0004090; F:carbonyl reductase (NADPH) activity; IEA:EC.::GO:0000166; F:nucleotide binding; IEA:InterPro. | | | | | | | | | | | 195 | Q3T046 | 245 | BDH2_BOVIN 3-hydroxybutyrate dehydrogenase ty... | 263 | 0.00000002 | 57.4 | 25 | 41 | GO:0005737; C:cytoplasm; IEA:UniProtKB-SubCell. | | | | | | | | | | GO:0003858; F:3-hydroxybutyrate dehydrogenase activity; IEA:EC.::GO:0000166; F:nucleotide binding; IEA:InterPro.::GO:0016628; F:oxidoreductase activity, acting on the CH-CH group of donors, NAD or NADP as acceptor; ISS:UniProtKB. | | | | | | | | | | GO:0042168; P:heme metabolic process; ISS:UniProtKB.::GO:0055072; P:iron ion homeostasis; ISS:UniProtKB.::GO:0019290; P:siderophore biosynthetic process; ISS:UniProtKB. | 196 | P55575 | 253 | Y4MP_RHISN Uncharacterized short-chain type d... | 257 | 0.00000002 | 57.4 | 29 | 40 | | | | | | | | | | | GO:0000166; F:nucleotide binding; IEA:InterPro.::GO:0016491; F:oxidoreductase activity; IEA:UniProtKB-KW. | | | | | | | | | | | 197 | O32185 | 109 | YUSS_BACSU Short-chain dehydrogenase/reductas... | 101 | 0.00000002 | 55.1 | 38 | 56 | | | | | | | | | | | GO:0000166; F:nucleotide binding; IEA:InterPro.::GO:0016491; F:oxidoreductase activity; IEA:InterPro. | | | | | | | | | | | 198 | O08699 | 266 | PGDH_RAT 15-hydroxyprostaglandin dehydrogenas... | 139 | 0.00000003 | 57.4 | 33 | 47 | GO:0005737; C:cytoplasm; ISS:UniProtKB. | | | | | | | | | | GO:0016404; F:15-hydroxyprostaglandin dehydrogenase (NAD+) activity; ISS:UniProtKB.::GO:0070403; F:NAD+ binding; ISS:UniProtKB.::GO:0004957; F:prostaglandin E receptor activity; ISS:UniProtKB. | | | | | | | | | | GO:0097070; P:ductus arteriosus closure; ISS:UniProtKB.::GO:0007565; P:female pregnancy; ISS:UniProtKB.::GO:0045786; P:negative regulation of cell cycle; ISS:UniProtKB.::GO:0030728; P:ovulation; ISS:UniProtKB.::GO:0007567; P:parturition; ISS:UniProtKB.::GO:0006693; P:prostaglandin metabolic process; ISS:UniProtKB.::GO:0070493; P:thrombin receptor signaling pathway; IEP:UniProtKB.::GO:0007179; P:transforming growth factor beta receptor signaling pathway; ISS:UniProtKB. | 199 | P00335 | 249 | RIDH_ENTAE Ribitol 2-dehydrogenase OS=Enterob... | 150 | 0.00000003 | 56.6 | 34 | 48 | | | | | | | | | | | GO:0000166; F:nucleotide binding; IEA:InterPro.::GO:0050255; F:ribitol 2-dehydrogenase activity; IEA:EC. | | | | | | | | | | | 200 | Q6NV34 | 300 | DECR2_DANRE Peroxisomal 2,4-dienoyl-CoA reduc... | 258 | 0.00000003 | 57.4 | 28 | 37 | GO:0005777; C:peroxisome; IEA:UniProtKB-SubCell. | | | | | | | | | | GO:0008670; F:2,4-dienoyl-CoA reductase (NADPH) activity; IEA:EC.::GO:0000166; F:nucleotide binding; IEA:InterPro. | | | | | | | | | | | 201 | A0PJE2 | 317 | DHR12_HUMAN Dehydrogenase/reductase SDR famil... | 128 | 0.00000003 | 57.4 | 31 | 50 | | | | | | | | | | | GO:0000166; F:nucleotide binding; IEA:InterPro.::GO:0016491; F:oxidoreductase activity; IEA:UniProtKB-KW. | | | | | | | | | | | 202 | P69167 | 260 | HSD_MYCTU 3-alpha-(or 20-beta)-hydroxysteroid... | 251 | 0.00000004 | 57 | 26 | 40 | GO:0005886; C:plasma membrane; IDA:MTBBASE. | | | | | | | | | | GO:0047044; F:androstan-3-alpha,17-beta-diol dehydrogenase activity; IDA:MTBBASE.::GO:0000166; F:nucleotide binding; IEA:InterPro. | | | | | | | | | | GO:0008202; P:steroid metabolic process; IDA:MTBBASE. | 203 | P69166 | 260 | HSD_MYCBO 3-alpha-(or 20-beta)-hydroxysteroid... | 251 | 0.00000004 | 57 | 26 | 40 | | | | | | | | | | | GO:0047044; F:androstan-3-alpha,17-beta-diol dehydrogenase activity; IEA:EC.::GO:0000166; F:nucleotide binding; IEA:InterPro. | | | | | | | | | | GO:0008202; P:steroid metabolic process; IEA:UniProtKB-KW. | 204 | Q920N9 | 244 | DCXR_CAVPO L-xylulose reductase OS=Cavia porc... | 260 | 0.00000004 | 56.6 | 26 | 40 | GO:0016020; C:membrane; IEA:UniProtKB-SubCell. | | | | | | | | | | GO:0050038; F:L-xylulose reductase (NADP+) activity; IDA:UniProtKB.::GO:0000166; F:nucleotide binding; IEA:InterPro. | | | | | | | | | | GO:0042732; P:D-xylose metabolic process; IEA:UniProtKB-KW.::GO:0006006; P:glucose metabolic process; IDA:UniProtKB.::GO:0051289; P:protein homotetramerization; IDA:UniProtKB.::GO:0005997; P:xylulose metabolic process; IDA:UniProtKB. | 205 | P40397 | 285 | YHXC_BACSU Uncharacterized oxidoreductase yhx... | 129 | 0.00000005 | 56.6 | 33 | 47 | | | | | | | | | | | GO:0000166; F:nucleotide binding; IEA:InterPro.::GO:0016491; F:oxidoreductase activity; IEA:UniProtKB-KW. | | | | | | | | | | | 206 | Q96LJ7 | 313 | DHRS1_HUMAN Dehydrogenase/reductase SDR famil... | 138 | 0.00000008 | 56.2 | 34 | 45 | GO:0005783; C:endoplasmic reticulum; IDA:LIFEdb. | | | | | | | | | | GO:0000166; F:nucleotide binding; IEA:InterPro.::GO:0016491; F:oxidoreductase activity; IEA:UniProtKB-KW. | | | | | | | | | | | 207 | Q1RKB7 | 241 | FABG_RICBR 3-oxoacyl-[acyl-carrier-protein] r... | 170 | 0.00000008 | 55.5 | 27 | 42 | | | | | | | | | | | GO:0004316; F:3-oxoacyl-[acyl-carrier-protein reductase (NADPH) activity; ISS:UniProtKB.::GO:0051287; F:NAD binding; IEA:InterPro.::GO:0050661; F:NADP binding; ISS:UniProtKB. | | | | | | | | | | GO:0030497; P:fatty acid elongation; ISS:UniProtKB.] | 208 | Q91VT4 | 236 | CBR4_MOUSE Carbonyl reductase family member 4... | 255 | 0.00000008 | 55.5 | 25 | 38 | GO:0005759; C:mitochondrial matrix; ISS:UniProtKB. | | | | | | | | | | GO:0070402; F:NADPH binding; ISS:UniProtKB.::GO:0008753; F:NADPH dehydrogenase (quinone) activity; ISS:UniProtKB.::GO:0048038; F:quinone binding; ISS:UniProtKB. | | | | | | | | | | GO:0006633; P:fatty acid biosynthetic process; IEA:UniProtKB-KW. | 209 | O54438 | 247 | FABG_PSEAE 3-oxoacyl-[acyl-carrier-protein] r... | 257 | 0.0000001 | 55.5 | 27 | 42 | | | | | | | | | | | GO:0004316; F:3-oxoacyl-[acyl-carrier-protein reductase (NADPH) activity; ISS:UniProtKB.::GO:0051287; F:NAD binding; IEA:InterPro.::GO:0050661; F:NADP binding; ISS:UniProtKB. | | | | | | | | | | GO:0030497; P:fatty acid elongation; ISS:UniProtKB.] | 210 | P42556 | 289 | PTR1_LEITA Pteridine reductase 1 OS=Leishmani... | 282 | 0.0000001 | 55.8 | 26 | 40 | | | | | | | | | | | GO:0000166; F:nucleotide binding; IEA:InterPro.::GO:0047040; F:pteridine reductase activity; IEA:EC. | | | | | | | | | | GO:0031427; P:response to methotrexate; IEA:UniProtKB-KW. | 211 | Q9BPX1 | 270 | DHB14_HUMAN 17-beta-hydroxysteroid dehydrogen... | 214 | 0.0000001 | 55.5 | 29 | 42 | GO:0005813; C:centrosome; IDA:HPA.::GO:0005829; C:cytosol; IDA:HGNC. | | | | | | | | | | GO:0004303; F:estradiol 17-beta-dehydrogenase activity; IDA:HGNC.::GO:0000166; F:nucleotide binding; IEA:InterPro.::GO:0005515; F:protein binding; IPI:IntAct.::GO:0047045; F:testosterone 17-beta-dehydrogenase (NADP+) activity; IDA:HGNC. | | | | | | | | | | GO:0006706; P:steroid catabolic process; IDA:HGNC. |